Prestige Consumer Healthcare

PBHNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.598 B

$54.85 +0.77%

Close of 7 Aug 2026

Revenue

$1.09B

#1481 by revenue

Earnings

$190.3M

#1027 by earnings

Shares outstanding

47,374,522

Latest filing cover page

P/E ratio

13.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#87Trevi TherapeuticsTRVI$2.63B
#88Zai LabZLAB$2.62B
#89Prestige Consumer HealthcarePBH$2.60B
#90PrecigenPGEN$2.59B
#91Nektar TherapeuticsNKTR$2.58B

Where these numbers come from

Share counts and financials for Prestige Consumer Healthcare are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.